Covered recipient · General Payments record
BENJAMIN J FLINK
Allopathic & Osteopathic Physicians Surgery
General Payments · PY2019–2024
$9,379.10
- Reported across 112 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $1,361.08 | 2 |
| Food and Beverage | $1,029.60 | 33 |
| Education | $13.24 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| TELA Bio, Inc. | $1,367.98 | 3 |
| Novo Nordisk AS | $465.97 | 16 |
| Teleflex LLC | $220.28 | 5 |
| INTUITIVE SURGICAL, INC. | $148.24 | 2 |
| Lilly USA, LLC | $93.49 | 5 |
| BOSTON SCIENTIFIC CORPORATION | $39.02 | 1 |
| VIVUS LLC | $34.60 | 2 |
| CONMED Corporation | $19.71 | 1 |
| Currax Pharmaceuticals LLC | $14.63 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Boston Scientific Corporation | $39.02 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092389964 | CMS |
| CONMED Corporation | $19.71 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142397891 | CMS |
| Currax Pharmaceuticals LLC | $14.63 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089509408 | CMS |
| INTUITIVE SURGICAL, INC. | $13.24 | 02/13/2024 | Education | Undisputed | 01/23/2026 | 1137224888 | CMS |
| INTUITIVE SURGICAL, INC. | $135.00 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137138802 | CMS |
| Lilly USA, LLC | $18.98 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136077145 | CMS |
| Lilly USA, LLC | $19.39 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136065082 | CMS |
| Lilly USA, LLC | $17.63 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136065786 | CMS |
| Lilly USA, LLC | $20.45 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136060932 | CMS |
| Lilly USA, LLC | $17.04 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136010143 | CMS |
| Novo Nordisk Inc | $18.17 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097093942 | CMS |
| Novo Nordisk Inc | $17.88 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096780916 | CMS |
| Novo Nordisk Inc | $5.91 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096653288 | CMS |
| Novo Nordisk Inc | $8.56 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097395751 | CMS |
| Novo Nordisk Inc | $22.12 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097323556 | CMS |
| Novo Nordisk Inc | $19.60 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096904329 | CMS |
| Novo Nordisk Inc | $114.15 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097494827 | CMS |
| Novo Nordisk Inc | $20.69 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097201735 | CMS |
| Novo Nordisk Inc | $19.03 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097661174 | CMS |
| Novo Nordisk Inc | $5.22 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096711633 | CMS |
| Novo Nordisk Inc | $22.38 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097493572 | CMS |
| Novo Nordisk Inc | $22.74 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097028254 | CMS |
| Novo Nordisk Inc | $124.14 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097233978 | CMS |
| Novo Nordisk Inc | $19.05 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097014196 | CMS |
| Novo Nordisk Inc | $17.60 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097430194 | CMS |
| Novo Nordisk Inc | $8.73 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097814068 | CMS |
| TELA Bio, Inc. | $660.74 | 04/26/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1154184307 | CMS |
| TELA Bio, Inc. | $700.34 | 04/28/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1154184309 | CMS |
| TELA Bio, Inc. | $6.90 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154184305 | CMS |
| Teleflex LLC | $17.20 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142078768 | CMS |
| Teleflex LLC | $24.39 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142091471 | CMS |
| Teleflex LLC | $132.81 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142074559 | CMS |
| Teleflex LLC | $34.92 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142095736 | CMS |
| Teleflex LLC | $10.96 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142078770 | CMS |
| VIVUS LLC | $21.25 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129415708 | CMS |
| VIVUS LLC | $13.35 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129415710 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.